Loading clinical trials...
Loading clinical trials...
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
Conditions
Locations
8
United States
Children's Hospital & Research Center Oakland
Oakland, California, United States
Georgia Regents University
Augusta, Georgia, United States
Children's Memorial Hospital
Chicago, Illinois, United States
Adult Comprehensive Sickle Cell Center, Duke University Medical Center
Durham, North Carolina, United States
Thomas Jefferson SCD Program
Philadelphia, Pennsylvania, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Start Date
March 31, 2010
Primary Completion Date
August 31, 2013
Completion Date
October 31, 2013
Last Updated
September 23, 2020
NCT05170412
NCT06526117
NCT06665997
NCT07431398
NCT07222475
NCT03050268
Lead Sponsor
UCSF Benioff Children's Hospital Oakland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions